Latest genomics Stories

BETHLEHEM, Pa., Dec. 6, 2012 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today its plans to create a laboratory that meets the Clinical Laboratory Improvement Amendments (CLIA) standards at the company's headquarters in Bethlehem, PA. Saladax has submitted applications for a CLIA license with both the state of...

Washington University School of Medicine Our bodies contain far more microbial genes than human genes. And a new study suggests that just as human DNA varies from person to person, so too does the massive collection of microbial DNA in the intestine. The research is the first to catalog the genetic variation of microbes that live in the gut, where they extract nutrients from food, synthesize vitamins, protect against infections, and produce compounds that naturally reduce inflammation....

[Watch NatGeo Video: Geno 2.0: The Greatest Journey Ever Told] Lee Rannals for redOrbit.com – Your Universe Online National Geographic unveiled the next phase of its Genographic Project, which aims to use DNA to map the history of human migration. The goal for the Genographic Project is to shine new light on humanity's past, offering up clues about humankind's journey across the planet over the past 60,000 years. "Our first phase drew participation from more than 500,000...

PHOENIX, Dec. 5, 2012 /PRNewswire/ -- Phoenix Children's Hospital announced the creation of the Ronald A. Matricaria Institute of Molecular Medicine today, with the goal to unlock genetic codes and develop drug therapies in real time to improve the outcome for thousands of young patients. To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/59399-phoenix-children-s-hospital-visionary-institute-of-molecular-medicine (Photo:...

LAUSANNE, Switzerland, December 5, 2012 /PRNewswire/ -- Biocartis launches its revolutionary detection platform, Dynamic Multi-Analyte Technology ("DMAT"): - New proteomic and nucleic acid platform provides ultra-high quality data analysis even at higher multiplex formats. - Platform launched well ahead of plan. Biocartis flips from a late-stage development company into a commercial business. Accurate and fast validation...

MOUNTAIN VIEW, Calif., Dec. 4, 2012 /PRNewswire/ -- 23andMe has received grants totaling $573,000 from the National Institutes of Health (NIH) to support three projects that utilize 23andMe's unique web-based research platform. These include projects to better understand the genetics of allergies; to assess accuracy of new sequencing technologies in clinical applications; and to develop tools that will take advantage of the genotypic and phenotypic information in the 23andMe...

Research published in the December 2012 journal Genetics shows that assessment of skin cancer risk is improved by accounting for genetic factors It's common knowledge that excessive UV exposure from sunlight raises your chances for skin cancer, but predicting whether someone will actually develop skin cancer remains difficult. In a new research report, scientists from the University of Alabama at Birmingham (UAB) and the University of Wisconsin–Madison show that the risk for skin cancer...

HOUSTON, Nov. 29, 2012 /PRNewswire/ -- The world's largest processor of full mitochondria sequences, Gene By Gene, Ltd., today announced the launch of DNA DTC to offer highly reliable and competitively priced genomic testing solutions to institutional customers as well as to the Direct-to-Consumer market. Genomic investigators at life science companies, contract research organizations, academic institutions and public-sector research facilities now have access to the company's...

PHOENIX, Nov. 29, 2012 /PRNewswire/ -- Although molecular medicine has been lauded as a game-changing science, patients have yet to see the benefits. Until now.On Dec. 4, one of the nation's largest children's hospitals, in collaboration with a major genomics research organization and a nationally regarded university, will announce a major venture that puts genomics research into clinical practice immediately to benefit children with terminal diagnoses.Unlike other children's...

BUFFALO, N.Y., Nov. 29, 2012 /PRNewswire/ -- Empire Genomics announced today it has acquired an exclusive license for patent pending novel genomic biomarkers from Emory University for use in developing a molecular diagnostic test that could help satisfy a large unmet medical need in determining ideal therapeutic treatment for multiple myeloma patients. Recent data point to certain genetic biomarkers that may identify which patients would benefit from receiving treatment with the...